Download Echocardiographic Assessment of Cardiac Anatomy

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Coronary artery disease wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Heart failure wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Electrocardiography wikipedia , lookup

Aortic stenosis wikipedia , lookup

Myocardial infarction wikipedia , lookup

Lutembacher's syndrome wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Antihypertensive drug wikipedia , lookup

Mitral insufficiency wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Ventricular fibrillation wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Transcript
Echocardiographic Assessment of Cardiac Anatomy
and Function in Hypertensive Subjects
DANIEL D. SAVAGE, M.D., PH.D., JAN I.M. DRAYER, M.D., WALTER L. HENRY, M.D.,
EMMETT C. MATHEWS, Jr., M.D., JAMES H. WARE, PH.D., JULIUS M. GARDIN, M.D.,
ESTELLE R. COHEN, B.S., STEPHEN E. EPSTEIN, M.D., AND JOHN H. LARAGH, M.D.
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
SUMMARY Cardiovascular complications are a major source of morbidity and mortality in hypertensive
patients. To assess the prevalence of anatomic and functional abnormalities of the heart in such patients, we
studied 234 asymptomatic subjects with mild-to-moderate systemic hypertension by echocardiography. After
adjusting the echocardiographic values for age and body surface area, we found abnormally increased ventricular septal and/or posterobasal free-wall thickness in 61% of the hypertensive subjects. We found increased
left atrial, aortic root, and left ventricular internal dimension (at end-diastole) in 5-7%, and decreased mitral
valve closing velocity (E-F slope) and left ventricular ejection fraction were noted in six and 15% of the subjects, respectively. Four percent of the patients had disproportionate septal thickening (i.e., ventricular septalto-left ventricular free-wall thickness ratio > 1.3). In contrast to the high prevalence of cardiac abnormalities
detected by echocardiography, less than 10% of the hypertensive subjects had abnormal 12-lead ECGs or abnormal chest x-rays. These findings demonstrate a high prevalence of cardiac abnormalities in a population of
asymptomatic hypertensive subjects. These abnormalities can be detected by echocardiography before they are
otherwise apparent.
compared the relative sensitivity of the echocardiogram, the standard 12-lead ECG, and the routine
chest x-ray for detecting cardiac abnormalities in
hypertensive subjects.
ABNORMALITIES OF CARDIAC STRUCTURE
and function occur in response to sustained hypertension. Before echocardiography, however, it was
difficult to detect early cardiac complications in
patients with hypertension. As a result, the first indication of cardiac involvement in many patients was
the development of overt congestive heart failure.
Echocardiography, which provides a direct means
of assessing both functional and anatomic abnormalities of the heart, has recently been applied to the
study of hypertensive subjects. The results of these
studies have suggested that increases in left atrial
dimension' and left ventricular wall thickness'"3 and
decreases in closing velocity (E-F slope) of the
anterior leaflet of the mitral valve3 occur frequently
even in the absence of other signs of cardiac involvement. However, similar changes have been reported to
occur in normal subjects as a result of aging.4 I
To determine whether some or all of the abnormalities reported in hypertensive subjects could be
related to age rather than blood pressure elevation, we
evaluated a population of subjects with mild-tomoderate hypertension and compared the results with
normal data using regression equations that accounted
for both body surface area and age. We also examined
the relation of the various echocardiographic
measurements to severity of hypertension. Finally, we
Materials and Methods
Subjects
Two hundred sixty hypertensive subjects and 124
normotensive subjects gave informed consent and
were studied by echocardiography. The hypertensive
subjects were selected from the outpatient hypertension clinic at the New York Hospital - Cornell
Medical Center. The following patients were excluded: 1) patients with malignant hypertension; 2)
patients on antihypertensive medications other than
diuretics, propranolol, clonidine, a-methyldopa or
guanethidine; and 3) patients with a history of angina
pectoris, myocardial infarction, atrial fibrillation or
congestive heart failure (i.e., orthopnea or paroxysmal
nocturnal dyspnea). Twenty-six of the 260 subjects
(10%) were excluded because their echocardiograms
were technically unsatisfactory for measurement of
the anatomic variables included in the study. The remaining 234 hypertensive subjects included 134 on
antihypertensive therapy at the time of the echocardiographic study and 100 who had had therapy discontinued for at least 3 weeks before the study. The selection and evaluation of the normotensive subjects are
extensively described in a previous report.4
Clinical characteristics of the hypertensive and normotensive subjects are shown in table 1. Blood
pressures were measured in the supine position with
standard sphygmomanometric methods. Mean
arterial pressure was estimated from the sum of the
diastolic pressure and one-third of the pulse pressure.
Seventy-three of the 134 patients (54%) on antihypertensive therapy and 53 of the 100 patients (53%) not on
From the Cardiology Branch, National Heart, Lung, and Blood
Institute, NIH, Bethesda, Maryland, and the Cardiovascular
Center, The New York Hospital-Cornell Medical Center, New
York, New York.
Presented in part at the 49th Annual Scientific Sessions,
American Heart Association, November 1976, Miami Beach,
Florida.
Address for reprints: Dr. Daniel D. Savage, Cardiology Branch,
National Heart, Lung, and Blood Institute, National Institutes of
Health, Building 10, Room 7B-15, Bethesda, Maryland 20014.
Received March 21, 1978; revision accepted November 7, 1978.
Circulation 59, No. 4, 1979.
623
624
CIRCULATION
VOL 59, No 4, APRIL 1979
TABLE 1. Clinical Characteristics of Subjects
Hypertensive subjects
Therapy
Therapy
discontinued
continued
Normotensive
subjects
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
Number of subjects
124
100
134
Sex-males:females
66:34
69:55
81:53
Age (years)
Mean - SD (range)
44 = 14 (19-70)
47
13 (19-69)
48 9 (24-67)
Race-whites:blacks
122:2
89:11
123:11
Systolic blood pressure
(mm Hg)
Mean SD (range)
121
13 (94-166)
150 20 (112-190)
144 - 23 (106-218)
Diastolic blood pressure
(mm Hg)
Mean - SD (range)
10 (80-150)
95
12 (68-140)
94
73 = 10 (50-90)
Number of subjects with
hypertensive retinopathy
Keith-Wagener grade > 2*
16 (16%)
35 (26%)
Number of subjects with
serum creatinine
> 1.7 mgWc (range)
77 = 7 _ (1 .7-2.7 mg%) 16 = 7 % (1.7-2.2 mg %)
*Only one hypertensive subject who was continued on therapy had grade 3 hypertensive retinopathy. All
other subjects had grades < 2.
such therapy had diastolic blood pressures lower than
95 mm Hg at the time of echocardiographic study.
However, all hypertensive subjects had had diastolic
blood pressure . 95 mm Hg on two or more
measurements within 1 year before study. Only two
hypertensive subjects had diastolic blood pressures
greater than 130 mm Hg at the time of echocardiographic study. None of the subjects had evidence of a
known secondary cause of hypertension by history,
physical examination or routine laboratory tests.
One hundred twenty-eight of the hypertensive subjects had systemic arterial blood pressure recorded
(sitting) on two or three clinic visits during the 6
months before echocardiographic study (with no
change in treatment status during these visits). The
average of these blood pressures was used for assessment of the relation of echocardiographic measurements to severity of hypertension.
Echocardiographic Measurements
M-mode echocardiograms were performed with the
patient on his or her left side. An Aerotech transducer
ultrasound receiver, a Honeywell 1856 Line Scan
Recorder, a Hewlett-Packard X-Y display, and a
custom-built video amplifier were used. Studies were
performed with the transducer in the fourth intercostal space near the left sternal edge. If necessary, the
transducer was moved laterally and/or to a different
interspace so that both mitral leaflets could be
visualized with the transducer perpendicular to the
chest wall. To obtain consistent and reproducible
recordings, the T-scan method was used.6
Figure 1 shows illustrative echocardiograms which
indicate where measurements were taken. The
thickness of the ventricular septum and posterobasal
left ventricular wall were measured at or slightly
below the tips of the mitral valve leaflets. Both
thicknesses were measured in the portion of the cardiac cycle that occurs after rapid ventricular filling but
before atrial systole (fig. lA).6 Posterobasal left ventricular wall was measured near the damped portion
of the record (fig. lA). Left ventricular transverse
dimensions at end-diastole and at end-systole were
measured in the same portion of the record and taken
as the maximal and minimal distances between septum and posterior left ventricular wall, respectively
(fig. lA).7 Left atrial dimension was measured as the
maximal distance between the posterior aortic root
wall and the posterior left atrial wall. Measurements
were taken in the damped portion of the record when
the ultrasonic beam passed through the aortic valve
leaflets.7-9 Aortic root dimension was measured in the
same portion of the recording. This measurement was
made from the midpoint of the line denoting the
anterior aortic root wall to the midpoint of the line
denoting the posterior aortic root wall at end-diastole.
The mitral valve E-F slope, corresponding to the rate
of early diastolic closure of the anterior leaflet of the
mitral valve, was measured at a point in which the excursion of the anterior mitral leaflet was maximal and
both leaflets were visualized (fig. lB).10
Values derived from the measurements included estimated left ventricular mass," percent fractional
shortening of the left ventricular transverse dimension," and left ventricular ejection fraction, which was
calculated using the cubed assumption to estimate left
ventricular volume.'3
Electrocardiographic Measurements
Two hundred seventeen of the hypertensive subjects
had standard 12-lead ECGs within 1 day to 12 weeks
of the echocardiographic study (median 1 day). No
ECHOCARDIOGRAPHY IN HYPERTENSIVE SUBJECTS/Savage et at.
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
0'71
TS
.JF,*,
625
\'
>
FIGURE 1. M-mode echocardiograms from hypertensive
subjects demonstrating where dimensions
were measured.
VS= ventricular septum; PW left ventricular posterobasal free wall; L VTDD = left ventricular transverse dimension at end-diastole; L VTD/, left ventricular transverse
dimension at end-systole. E-F slope (and not E-F0) was
measured. ICM indicates I cm.
subject had a change in treatment status during the
time between electrocardiographic and echocardiographic study. The Romhilt-Estes scoring system'4
was used to assess electrocardiographic evidence of
left ventricular hypertrophy. A point score of four indicated' probable left ventricular hypertrophy and five
or more points indicated definite left ventricular
hypertrophy.
Statistical Analyses
Statistical analyses used included standard regression analysis and analysis of covariance. Where appropriate, the t test or the chi square test was used to
assess statistical significance.
Chest Roentgenographic Measurements
on Echocardiographic Measurements
One hundred sixty-eight of the hypertensive subjects
had routine posteroanterior chest x-rays within 1 day
to 12 weeks of the echocardiographic study (median 1
day). As with the ECG, no patient had a change
in treatment status during the time between the chest
x-ray and the echocardiogram. A cardiothoracic ratio
> 0.5 was considered evidence of left ventricular
of Hypertensive Subjects
Results
Effects of Body Surface Area and Age
enlargement."
To assess the effect of body surface area on echocardiographic measurements, each hypertensive subject
was placed into 1 of 5 decades by age. For each age
decade the echocardiographic measurements were
plotted vs the previously derived appropriate root
function'6 of body surface area. The slopes from these
plots were compared with those of similar plots
626
CIRCULATION
18 r
TABLE 2. Blood Pressure Data of Hypertensive Subjects in
Each Age Group
en
Age group
(years)
21-30
31-40
41-50
51-60
61-70
(24)
16 F
(64)
E
E
z
14
'(88)
k
UJ
z
C-)
I
I- 12 F
(29)
M:
U) 10 F
0J
(24
*Mean
,:,(!,1I7I
;I
8
6
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
I
20
30
I
40
50
AGE IN YEARS
I
I
60
70
derived from norm(otensive subjects.4 No significant
difference was found between these slopes from hypertensive and normo)tensive subjects for any of the
echocardiographic nneasurements, including left ventricular transverse dimension at end-diastole and at
end-systole, ventrictilar septal thickness, left ventricular free-wall thickmness, left ventricular mass, left
atrial and aortic ro)ot dimensions, and mitral valve
E-F slope. As in nor*motensive subjects,4 ejection fraction and percent fraictional shortening were the only
echocardiographic nneasurements in the hypertensive
<C
10
00O
ZHF
-Z
wF
z
w
Z
ID
w
29
29
64
88
24
Blood pressure (mm Hg)
Diastolic*
Systolic*
137 12
91 9§
138 20
94 16
143 14
96 9
150 19t 96 9
167 19: 95 8
SD.
* Mean For Hypertensive Subjects
o Mean For Normotensive Subjects
FIGURE 2. Effect of age on ventricular sep tal thickness In
hypertensive and norrnotensive subjects. Each echocardiographic value was adjiusted by regression analysis to a body
. .
.
surface area of 1.8 n 2*. Numbers
in parentheses indicate.
numbers of subjects. JIn this and all subsequent figures the
symbol I = mean ± SL
z 20
f
Number of
subjects
tMean systolic blood pressure was significantly higher than
that of each of the three younger age groups (p <0.01).
tIean systolic blood pressure was significantly higher than
that of eaah of the four younger age groups (p <0.001).
§Mean diastolic blood pressture was significantly lower than
those of the subjects aged 41 to 60 (p <0.02) but was similar
to suibjects in the other age groups (p >0.05).
z
w
I_
VOL 59, No 4, APRIL 1979
subjects which were independent of body surface area.
To assess the effect of age on the echocardiographic measurements of hypertensive subjects, the
measurements were each adjusted to a body surface
area of 1.8 m2 using regression equations derived in
our laboratory. These adjusted values were subdivided into 5 decades as before, and the values were
averaged. The adjusted values for ventricular septal
thickness are plotted vs age in figure 2. As in the study
of normal subjects,4 ventricular septal thickness, freewall thickness, left atrial dimension and aortic root
dimension increased, while mitral valve E-F slope
decreased with increasing age. Left ventricular
transverse dimension (at end-systole and at enddiastole), ejection fraction and percent fractional
shortening showed no significant changes with age.
The magnitude of change in each echocardiographic
measurement with age is summarized in figure 3.
Blood pressure data for each of the five age groups is
given in table 2. The changes in echocardiographic
measurements with age remained evident after adjustment (using covariate analysis) for differences in blood
pressures among the five age groups.
SEPTAL THICKNESS
LEFT ATRIAL DIMENSION
_FREE=-WREE-WALL
_
THICKNESS
__AORTIC ROOT DIMENSION
0- : 7--7_ -._.
FRACTION
-1
-10
-20
-20)
-40
FIGURE 3. Effect of age on echocar-
diographic measurements in hypertensive
subjects. Mean echocardiographic values for
each age decade is compared with that of
hypertensive subjects in the 21-30 age group
after adjustment of echocardiographic
values to a body surface area of 1.8 m2,
*For mitral valve E-F slope n
-50
AGE IN YEARS
=
227.
,
ECHOCARDIOGRAPHY IN HYPERTENSIVE SUBJECTS/Savage et al.
SEPTAL THICKNESS
FREE-WALL THICKNESS
MITRAL VALVE
E-F SLOPE* (mm/sec)
'(206)
LV MASS (grams)
30 F
k
175
600 F
150
700
E
E
z
,
.t:
A
w
20
z
500
A
- .40
1
ii'
,)1-1, *A
400
---410690"
...
-.o
.'
,
_''-1041."
.AA
40**A&"
.-4MDA&"
.-
-1
,
100_
*AAA
A
.Q&l 1.8486.;.16.6665=2612122t=
3,-,'--Ab9*AAA
r-
..
±4
'A
D.)O"
-j
>
-J
10
125
4!!.A
A
I-IDooe"
I
300
4040416SAAA
X-4-
4.X
75
..* 1000"
.400AAAAA
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
-j
Ljl .I
200
,1R
I ;.j
O
627
OAA&A"
A
00"
4MAAA
O"
A
9O"
e
50
35
o1
IL
I4
1
FIGURE 4. Distribution of absolute echocardiographic measurements of ventricular septum, left ventricular free wall, mitral valve E-F slope, and derived left ventricular mass in 234 hypertensive subjects. On this
and all subsequent figures: open circles = patients on no medication, closed circles = patients on antihypertensive medication other than propranolol, and closed triangles = patients on propranolol with or without
other antihypertensive medication. LV = left ventricular. *For mitral valve E-F slope n = 227.
LEFT ATRIAL
DIMENSION
LVTDS
LVTDD
AORTIC ROOT
DIMENSION
I
60
OA
A.
A
I.:
OSAA
0
00"
E 50
E
z
.,. OAAAAAA
41408SAAAA
"A
A
40
SO
S"
OOAAAAAA
*-0
.
z
w
-:10
-:4
4a"
0
-:-,. -,(
.
301z
w
..-
I
I
.-.
1-
-4"WAA
.-
.-
,
's
&A"
O"
400
-
A&
0
20 F
.-..
OA
.
00
-A
O"
10i
n
u
I
FIGURE 5. Distribution of absolute echocardiographic measurements of left ventricular dimensions at enddiastole and end-systole, and left atrial and aortic root dimensions in 234 hypertensive subjects.
L VTDD = left ventricular transverse dimension at end-diastole; L VTD, = left ventricular transverse dimension at end-systole.
628
CIRCULATION
LV EJECTION
FRACTION
LV FRACTIONAL
SHORTENING
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
z
0 50
0u
0
1
FIGURE 6. Distribution of ejection fraction and percent
fractional shortening measured by echocardiography in 234
hypertensive subjects. Shaded areas represent the 95%
prediction interval derived from normal data. LV left
ventricular.
Prevalence of Anatomic and Functional Echocardiographic
Abnormalities in Hypertensive Subjects
Figures 4, 5 and 6 show the distribution of the absolute echocardiographic measurements of the hypertensive subjects. Since the frequencies of echocardiographic abnormalities in subjects who remained on
therapy, including the subgroup on propranolol, was
similar to that of subjects who had therapy discontinued, we considered their data together. The effect of
hypertension on the various echocardiographic
measurements was assessed by calculating the ratio of
the actual measurement to the predicted value for
each hypertensive subject. The predicted value was
calculated using our previously derived regression
equations4 which account for the effects of both age
and body surface area. Figures 7 and 8 show the dis-
VOL 59, No 4, APRIL 1979
TABLE 3. Prevalence of Echocardiographic Abnormalities in
234 Hypertensive Subjects
Percent of
Echocardiographic measurement
patients*
Ventricular septal thickness
50
Left ventricular free-wall thickness
61
Disproportionate septal thickeningt
4
Left ventricular mass
51
Left ventricular transverse dimension
at end-diastole
5
Left ventricular transverse dimension
at end-systole
12
Left atrial dimension
5
Aortic root dimension
7
15
Ejection fraction
Percent fractional shortening
13
MIitral valve E-F slope:
6
*Echocardiographic values were considered abnormal if
they were above (or below for ejection fraction, percent
fractional shorteniing and mitral valve E-F slope) the 95%0
prediction interval derived from normotensive subjects.
tDisporportionate septal thickening = ratio of ventricular
septal thickness to free-wall thickness > 1.3.
tThe number of subjects who had mitral valve E-F slope
measured was 227.
tribution of these ratios for each of the echocardiographic measurements of the hypertensive subjects.
Table 3 summarizes the percentage of echocardiographic abnormalities that fall above (or below for
ejection fraction, percent fractional shortening, and
mitral valve E-F slope) the 95% prediction interval
derived from the normotensive subjects.
Mean ventricular septal thickness, left ventricular
free-wall thickness, and left ventricular mass for the
hypertensive subjects were significantly greater than
those of normal subjects (p < 0.001) (fig. 7). Mean
values of left ventricular transverse dimensions (at
end-diastole and at end-systole), left atrial and aortic
root dimensions, left ventricular ejection fraction, and
percent fractional shortening for the hypertensive subjects were not significantly different from values in
normal subjects (figs. 6 and 8). There was no significant correlation (positive or negative) between ventricular septal or left ventricular free-wall thickness and
ejection fraction. Although only a small number of
hypertensive subjects had a mitral valve E-F slope
below the 95% prediction interval, the mean E-F slope
of hypertensive subjects was significantly lower than
that of normal subjects (p < 0.001) (fig. 7).
Nine hypertensive subjects had ventricular septal
thickening that was disproportionate to the left ventricular free-wall thickness (i.e., septal-free wall ratio
> 1.3). Their measured septal thicknesses ranged
from 15-27 mm, with septal-free wall ratios from
1.3-1.9. None of the nine had systolic anterior motion
of the anterior leaflet of the mitral valve. However,
one subject who had concentric left ventricular wall
thickening did have systolic anterior motion of the
anterior mitral leaflet.
O'-~ ~ ~ -. .:- . -. .
ECHOCARDIOGRAPHY IN HYPERTENSIVE SUBJECTS/Savage et al.
FREE-WALL
THICKNESS
SEPTAL
THICKNESS
225
Lu
200
175
LV MASS
629
MITRAL VALVE
E-F SLOPE*
-,(299)
*(244)
(230)
.
FIGURE 7. Distribution
of
echocar-
diographic ventricular septal thickness, left
r 0 ;|; : ventricular free-wall thickness, left ventric............ular mass, and mitral valve F-F slope in 234
. E W
1 125 t
F-
125
T Wt
1 - -0 --p°0 20 0 0 0 0 0 040:0 0 0 0 00000000000:......hypertensive subjects. Each value is plotted
S
slope.
E
W ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~..........
...
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
O~~~~~~~~~~~~~~~~~~~~~~~.....
...
25
.
D
__
,'.-~~~~~~...
.
....---
]<7Xr
LVTDD
LVTD5
LEFT ATRIAL
DIMENSION
a-~ ~ ~~~~~~....
17
ie
AORTIC ROOT
DIMENSION
rmnrmldt.Sae
< 150
-J yPL
Z1252.
.....0.
<
Z
50___
z
25___
w.
I
I
I
_
o_ _
FIGURE 8. Distribution of echocardiographic left ventricular transverse dimension at end-diastole
(L VTDD) and at end-systole (L VTD3), and left atrial and aortic root dimensions in 234 hypertensive subjects. Each value is plotted as a percentage of the predicted value determined from normal data. Shaded
areas represent the 95% prediction interval derived from normal data.
ra
630
CIRCULATION
TABLLE 4. Correlation Coefficients of Blood Pressure vs Echocardiographic .Ieasurcertents in 128 Hypertensive Subjects
Systolic
blood
pressure
Diastolic
blood
pressure
Mean
arterial
pressure
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
Ventricular septal
thickness
0.209*
0.314$
0.346t
Left ventricular
free-wall thickness
0.291$
0.430$
0.4681
Left ventricular mass
0.231t
0.319$
0.311t
Left ventricular transverse
dimension at end-diastole 0.022
-0.026
-0.003
Left ventricular transverse
dimension at end-systole - 0.083
0.010
-0.040
Left atrial dimension
0.204*
0.166
0.208*
Aortic root dimension
-0.082
0.010
-0.040
Ejection fraction
0.120
-0.029
0.050
Percent fractional
0.136
-0.032
shortening
0.058
Mitral valve E-F slope
-0.001
-0.064
-0.037
*p <0.05.
tp <0.01.
$p <0.001.
Relation of Echocardiographic Measurements
to Severity of Hypertension
One hundred twenty-eight of the hypertensive subjects had systemic arterial blood pressure recorded on
two or three clinic visits during the 6 months before
echocardiographic study (with no change in treatment status during these clinic visits). There was only
a modest (but statistically significant) correlation
between the averaged mean arterial pressures
recorded during these visits and the ratios of actual to
predicted values for ventricular septal thickness, left
ventricular free-wall thickness, left atrial dimension
and left ventricular mass (table 4). No significant correlations were found between mean arterial blood
pressure and aortic root dimension, left ventricular
transverse dimension (at end-systole or end-diastole),
left ventricular ejection fraction or mitral valve E-F
slope.
Comparison of the Echocardiogram with the 12-Lead
Electrocardiogram and the Chest X-ray
The echocardiogram was compared with both the
standard 12-lead ECG and the routine chest x-ray for
detecting cardiac abnormalities in hypertensive subjects. Probable or definite left ventricular hypertrophy was detected by ECG in seven of the 217 hypertensive subjects (3%) who had recent ECGs. Six of
these seven subjects (86%) had increased left ventricular mass by echocardiogram and the seventh had an
echocardiographic left ventricular mass at the upper
limit of normal (as well as increased left ventricular
free-wall thickness). Probable or definite left ventricular hypertrophy by ECG was detected in only six of
108 hypertensive subjects (6%) who had increased left
ventricular mass by echocardiogram.
VOL 59, No 4, APRIL 1979
Left ventricular enlargement was detected by chest
x-ray in nine of 168 hypertensive subjects (5%) who
had recent chest x-rays. Six of the nine subjects (67%)
had increased left ventricular wall thickness and increased left ventricular mass by echocardiogram. Left
ventricular enlargement was detected by chest x-ray in
only six of 81 hypertensive subjects (7%) who had left
ventricular enlargement (at end-diastole) or increased
left ventricular mass by echocardiogram, or both.
Discussion
Previous studies of normotensive subjects without
clinically apparent heart disease have shown changes
in echocardiographic measurements with increasing
age and body surface area.4' I The changes associated
with increasing age include increased aortic root and
left atrial size, increased left ventricular wall
thickness, and decreased mitral valve E-F slope. In the
present study echocardiographic measurements of
hypertensive subjects showed changes with increasing
age and body surface area similar in direction and
degree to those seen in normotensive subjects. The
magnitude of these changes suggests that the effects of
both age and body surface area should be accounted
for in any attempt to assess the effects of hypertension on echocardiographic measurements. This was
accomplished in the present study by using the ratio of
actual to predicted values. These predicted values were
based on previously derived regression equations from
normal subjects.4
Using this approach, structural abnormalities of the
heart were detected in more than 60% of our population of subjects with mild-to-moderate hypertension.
The most frequent abnormalities were ventricular septal and left ventricular free-wall thickening and increased left ventricular mass. Similarly, Schlant et al.2
found increased left ventricular mass by echocardiography in 36 of 73 (49%) of their hypertensive subjects.
The mean values and scatter of the data of left atrial,
aortic root, end-diastolic and end-systolic left ventricular dimensions for our hypertensive population were
similar to those found for the normotensive population. If published criteria7 for left atrial enlargement
(even those adjusted for body surface area) were used
for our hypertensive population, the prevalence of left
atrial enlargement would have been three times as
high as that found after accounting for both age and
body surface area (i.e., 15% rather than 5%). Thus, left
atrial enlargement was uncommon in our hypertensive subjects, whether or not they had left ventricular
hypertrophy, and did not appear to be an early indicator of cardiac involvement in hypertensive disease,
as we previously thought.'7 Dunn et al.' found larger
echocardiographic left atrial dimensions in hypertensive subjects than in normal subjects. However, the
hypertensive subjects in their study were older than the
normal subjects. Thus, the larger left atrial dimensions might at least partially be explained by changes
which normally occur with age, rather than by the
effects of hypertension.
In our study, modest but statistically significant
ECHOCARDIOGRAPHY IN HYPERTENSIVE SUBJECTS/Savage et al.
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
correlations were found between systemic arterial
blood pressure and left ventricular wall thicknesses,
left ventricular mass and left atrial dimension. Schlant
et al.2 found poorer correlations between left ventricular wall thicknesses and diastolic pressure than those
found in the present study. However, their series was
smaller than ours. In addition, they correlated left
ventricular wall thicknesses with a single diastolic
pressure measurement, while two or more measurements from separate clinic visits were used in the present study.
Disproportionate septal hypertrophy has been reported in 47%,18 30%,19 10%,' and less than 1%2 of subjects with hypertension. We found this abnormality in
4% of our hypertensive subjects (nine of 234). Exclusion of subjects with angina pectoris, evidence of
myocardial infarction and severe hypertension from
our study population may have lowered the prevalence
of disproportionate septal thickening. However, it
would appear that this abnormality is uncommon in
subjects with mild-to-moderate hypertension.
We did not study the relatives of patients who had
disproportionate septal thickening and, therefore, do
not know whether this abnormality represents
genetically transmitted hypertrophic cardiomyopathy
(i.e., asymmetric septal hypertrophy), is an atypical
form of left ventricular wall thickening secondary to
hypertension, or neither. Of note, a recent necropsy
study of hypertensive subjects from our laboratory20
showed that the disproportionate septal thickening
present in two patients with hypertension did not have
the features characteristic of genetic hypertrophic cardiomyopathy.
Left ventricular systolic function (as assessed by
ejection fraction) was reduced in 35 of the 234 hypertensive subjects (15%) in the present study, and in two
subjects ejection fraction was considerably reduced
(23% and 35%). This was found despite our exclusion
of subjects with severe hypertension. Two other
echocardiographic studies, which included subjects
with more severe hypertension, showed that mean left
ventricular ejection fraction diminished as the severity
of hypertension increased." 2 Left ventricular diastolic
function (as measured by mitral valve E-F slope) was
below the lower limit of normal in only 14 of the 227
hypertensive subjects (6%), but overall was shifted
toward low-normal values so that the mean E-F slope
of the hypertensive population was significantly below
that of the normotensive population.
The echocardiogram appears to be superior to the
routine chest x-ray and the standard 12-lead ECG for
detecting cardiac abnormalities in hypertensive subjects. Thus, while the echocardiogram identified an increase in estimated left ventricular mass in over 50%
of the patients, the chest x-ray and the ECG identified
left ventricular enlargement or hypertrophy in less
than 10%. Echocardiograms of sufficient quality to
make all measurements could not be obtained in some
subjects. More important, ECGs and chest x-rays
may convey different information than echocardiograms, and therefore, echocardiograms should be used
in conjunction with them, rather than instead of them.
631
These findings are consistent with those of Schlant et
al.2 and Pisarczyk and Ross.2'
In summary, echocardiography identifies anatomic
and functional cardiac abnormalities in a large percentage of asymptomatic hypertensive subjects before
abnormalities are detected by ECG or chest x-ray.
This conclusion is strengthened by correcting the
echocardiographic values for effects of body surface
area and age. Whether echocardiography should be
used for routine screening of such subjects will depend
partly on the prognostic significance of these abnormalities.
Acknowledgments
The authors gratefully acknowledge the excellent technical
assistance of Joyce McKay and Cora Burn in obtaining the echocardiograms. The assistance of Pamela Peters and Rose Aceto in the
logistics of evaluating the large number of patients is greatly appreciated. We also acknowledge Erica Brittain for help with the
statistical analyses.
References
1. Dunn FG, Chandraratna P, deCarvallo JGR, Basta LL,
Frohlich EF: Pathophysiologic assessment of hypertensive
heart disease with echocardiography. Am J Cardiol 39: 789,
1977
2. Schlant RC, Felner JM, Heynsfield SB, Gilbert CA, Shulman
NB, Tuttle EB, Blumenstein BA: Echocardiographic studies of
left ventricular anatomy and function in essential hypertension.
Cardiovasc Med 2: 477, 1977
3. Mashiro I, Kinoshita M, Tomonaga G, Hoshino T, Shimono
Y, Kusukawa R: Echocardiographic observations in hypertension. Jpn Circ J 39: 1097, 1975
4. Gardin JM, Henry WL, Savage DD, Ware JH, Burn C, Borer
JS: Echocardiographic measurements in normal subjects:
evaluation of an adult population without clinically apparent
heart disease. J Clin Ultrasound. In press
5. Gerstenblith G, Frederiksin J, Yin FCP, Fortuin NJ, Lakatta
EF, Weisfeldt ML: Echocardiographic assessment of a normal
adult aging population. Circulation 56: 273, 1977
6. Henry WL, Clark CE, Epstein SE: Asymmetric septal hypertrophy (ASH): echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 47: 225,
1973
7. Feigenbaum H: Echocardiography, 2nd ed. Philadelphia, Lea
and Febiger, 1976, pp 236, 311, 464
8. Brown OR, Harrison DC, Popp RL: An improved method for
echocardiographic detection of left atrial enlargement. Circulation 50: 58, 1974
9. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood
DR, Itscoitz SB, Epstein SE: Relation between echocardiographically determined left atrial size and atrial fibrillation.
Circulation 53: 273, 1976
10. Quinones MA, Gaasch WH, Waisser E, Alexander JK: Reduction in the rate of diastolic descent of the mitral valve echogram in patients with altered left ventricular diastolic pressurevolume relations. Circulation 49: 246, 1974
ll. Troy BL, Pombo J, Rackley CE: Measurements of left ventricular wall thickness and mass by echocardiography. Circulation
45: 602, 1972
12. Fortuin NJ, Hood WP Jr, Sherman ME: Determination of left
ventricular volume by ultrasound. Circulation 44: 575, 1971
13. Popp RL, Harrison DC: Ultrasonic cardiac echography for
determining stroke volume and valvular regurgitation. Circulation 41: 493, 1969
14. Romhilt DW, Estes EH Jr: A point-score system for the ECG
diagnosis of left ventricular hypertrophy. Am Heart J 75: 752,
1968
15. Paul LW, Juhl JH: The Essentials of Roentgen Interpretation,
2nd ed. New York and London, Harper and Row, 1965, p 784
CIRCULATION
632
16. Henry WL, Ware JH, Gardin JM, Hepner SI, McKay J,
Weiner M: Echocardiographic measurements in normal subjects: growth-related changes that occur between infancy and
early adulthood. Circulation 57: 278, 1978
17. Drayer JIM, Savage DD, Henry WL. Mathews EC Jr., Laragh
JH, Epstein SE: Incidence of echocardiographic left ventricular hypertrophy and left atrial enlargement in essential hypertension. (abstr) Circulation 54 (suppl II): 11-233, 1976
18. Criley JM, Blaufuss AH, Abbasi AS: Nonobstructive IHSS.
Circulation 52: 963, 1975
VOL 59, No 4, APRIL 1979
19. Toshima H, Koga Y, Yoshioka H, Ayiyoshi T, Kimura N:
Echocardiographic classification of hypertensive heart disease:
a correlative study with clinical features. Jpn Heart J 16: 377.
1975
20. Maron BJ, Edwards JE, Epstein SE: Occurrence of disproportionate ventricular septal thickening in patients with systemic
hypertension. Chest 73: 466, 1978
21. Pisarczyk MJ, Ross AM: Cardiac measurements in hypertension: echocardiogram, electrocardiogram and x-ray comparison. (abstr) Am J Cardiol 37: 162, 1976
Carotid Baroreflex Function in Young Men
with Borderline Blood Pressure Elevation
DWAIN L. ECKBERG, M.D.
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
SUMMARY Carotid baroreflex function was assessed in 10 normotensive young men and 20 age-matched
subjects with borderline hypertension (successive blood pressures above and below 140/90 mm Hg) by measuring sinus node responses to brief neck suction. Subjects with borderline hypertension were divided into two
equal groups according to their average systolic arterial pressures. Baroreflex responses were reset to function
at higher pressure levels than normal in subjects with mild borderline hypertension, but reflex sensitivity was
normal. Responses were also reset in subjects with more severe borderline hypertension, but reflex sensitivity
was subnormal. The results suggest that a gradation of baroreflex responsiveness exists among patients
classified as having borderline hypertension: Subnormal responsiveness was found in those subjects whose
resting average systolic arterial pressure was 140 mm Hg.
SOON AFTER THE CAROTID ARTERIAL
BAROREFLEX was discovered, Koch and Mies' and
Volhard' suggested that defective baroreflex buffering
of blood pressure might cause essential hypertension.
Despite numerous subsequent attempts to delineate
hypertensive mechanisms, the role of the arterial baroreflex in the pathogenesis of hypertension remains an
enigma. The validity of the theory of Koch and Mies
and Volhard has been questioned,3 but the theory has
not been discredited altogether. The study of Bristow
and co-workers4 supports their postulate: In their
study arterial baroreceptor-cardiac reflex responses
were found to be strikingly depressed in patients with
moderate (average mean arterial pressure 123 mm
Hg), sustained hypertension. In these patients, baroreceptor reflex malfunction might have contributed to
the development of hypertension, or it might have
been a consequence of hypertension.
If a defective baroreceptor reflex mechanism causes
hypertension, subnormal baroreflex responses should
From the Cardiovascular Center, the Cardiovascular Division,
the Department of Internal Medicine, and the Veterans Administration and University Hospitals, the University of Iowa College of
Medicine, Iowa City, Iowa.
Supported by grants HL 14388 and HL 18083 from the Veterans
Administration and the National Institutes of Health.
Dr. Eckberg is a Clinical Investigator for the Veterans Ad-
ministration.
Address for reprints: Dwain L. Eckberg, M.D., Cardiovascular
Research, McGuire VA Hospital, Richmond, Virginia 23249.
Received August 7, 1978; revision accepted November 8, 1978.
Circulation 59, No. 4, 1979.
be found in patients with mild degrees of blood
pressure elevation. Data on this issue are conflicting.
Takeshita and associates5 found subnormal baroreflex
responses in young men whose average blood pressure
was 160/82 mm Hg, but Julius6 found normal
responses in borderline hypertensive patients whose
blood pressures were reported to be lower than those
studied by Takeshita and co-workers. I have
attempted to clarify this issue by using new techniques to measure baroreflex responses of asymptomatic young men whose blood pressures oscillate
above and below 140/90 mm Hg.
Methods
Seven intensities of neck suction were delivered
briefly to stretch carotid baroreceptors of young men
with normal blood pressures and young men with
borderline hypertension (defined as blood pressures
above and below 140/90 mm Hg on successive examinations). Sinus node responses were measured.
Hypertensive and Normal Volunteers
Volunteers, ages 19-25 years, were recruited from
900 university students whose blood pressures were
measured during registration. Blood pressures of each
volunteer were measured two to four (average 2.85)
times with subjects in the sitting position, after 10
minutes of rest. Weight, height and skin fold
thickness, measured in the midline midway between
the chin and the upper margin of the thyroid cartilage
were also measured.
Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects.
D D Savage, J I Drayer, W L Henry, E C Mathews, Jr, J H Ware, J M Gardin, E R Cohen, S E
Epstein and J H Laragh
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
Circulation. 1979;59:623-632
doi: 10.1161/01.CIR.59.4.623
Circulation is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231
Copyright © 1979 American Heart Association, Inc. All rights reserved.
Print ISSN: 0009-7322. Online ISSN: 1524-4539
The online version of this article, along with updated information and services, is located on
the World Wide Web at:
http://circ.ahajournals.org/content/59/4/623
Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally
published in Circulation can be obtained via RightsLink, a service of the Copyright Clearance Center, not the
Editorial Office. Once the online version of the published article for which permission is being requested is
located, click Request Permissions in the middle column of the Web page under Services. Further
information about this process is available in the Permissions and Rights Question and Answer document.
Reprints: Information about reprints can be found online at:
http://www.lww.com/reprints
Subscriptions: Information about subscribing to Circulation is online at:
http://circ.ahajournals.org//subscriptions/